Tumour necrosis factor levels during acute rejection and acute tubular necrosis in renal transplant recipients.
Plasma tumour necrosis factor levels were measured serially in 16 patients following renal transplantation, and in 10 patients on haemodialysis and in 12 patients on peritoneal dialysis. The patients on peritoneal dialysis had lower plasma TNF levels than the patients on haemodialysis. There was a decrease in TNF levels immediately following renal transplantation; this is probably related to the bolus doses of methylprednisolone administered intra-operatively. Patients with acute rejection had higher levels of TNF than non-rejecting patients. The increase in TNF levels in rejecting patients was observed 2 days before the clinical manifestation of acute rejection. There was a marked decrease in TNF levels in rejecting patients in response to treatment with steroids. Patients with delayed graft function had higher levels of TNF on the first post-operative day compared to patients with immediate function. These changes in plasma TNF levels following renal transplantation have important clinical and therapeutic implications.
Wiggins
M C
MC
Department of Surgery, and Medical Research Council Liver Centre, University of Cape Town, South Africa.
Bracher
M
M
Mall
A
A
Hickman
R
R
Robson
S C
SC
Kahn
D
D
D000208:Acute Disease; D000328:Adult; D006084:Graft Rejection / Q000209:etiology / Q000276:immunology*; D006801:Humans; D015592:Immunoradiometric Assay; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000276:immunology*; D007683:Kidney Tubular Necrosis, Acute / Q000209:etiology / Q000276:immunology*; D011446:Prospective Studies; D013997:Time Factors; D014181:Transplantation Immunology; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
D014409:Tumor Necrosis Factor-alpha